Neuberger Berman Group
DNA icon

Neuberger Berman Group’s Ginkgo Bioworks DNA Stock Holding History

Neuberger Berman Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,593
Closed -$34.7K – 1951
2024
Q2 		$34.7K Sell
2,593
-16,128
-86% -$481K ﹤0.01% 1854
2024
Q1 		$869K Sell
18,721
-25,565
-58% -$1.32M ﹤0.01% 1325
2023
Q4 		$2.99M Sell
44,286
-8,960
-17% -$549K ﹤0.01% 1028
2023
Q3 		$3.86M Buy
53,246
+212
+0.4% +$16.9K ﹤0.01% 940
2023
Q2 		$3.95M Sell
53,034
-3,892
-7% -$230K ﹤0.01% 941
2023
Q1 		$3.03M Sell
56,926
-1,110
-2% -$70.3K ﹤0.01% 984
2022
Q4 		$3.92M Buy
58,036
+14,100
+32% +$1.3M ﹤0.01% 914
2022
Q3 		$5.48M Buy
43,936
+1,191
+3% +$142K 0.01% 864
2022
Q2 		$4.07M Sell
42,745
-8,190
-16% -$999K ﹤0.01% 947
2022
Q1 		$8.21M Buy
50,935
+2,532
+5% +$493K 0.01% 845
2021
Q4 		$16.1M Sell
48,403
-17,043
-26% -$8.1M 0.01% 740
2021
Q3 		$30.3M Buy
+65,446
New +$31.9M 0.03% 581

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return